We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Achilles

News List

Cancer Research UK reports ‘most successful financial year’ for its spinouts pharmatimes
July 16, 2021
Cancer Research UK (CRUK) has reported record levels of investment for its spinout portfolio, with the ‘most successful financial year’ recorded to date.
Achilles' US IPO closed with proceeds of $175m pharmatimes
April 09, 2021
Cancer Research UK spinout Achilles Therapeutics has closed its Initial Public Offering in the US bagging gross proceeds of $175.5 million.
Personalised cell therapy developer Achilles closes £100m round pharmaceutical-technology
September 05, 2019
UK-based Achilles Therapeutics has announced the closing of its £100m Series B financing round, which was led by new investor RA Capital Management and founding investor Syncona.